changing your setting. We'll assume that you are happy to receive all cookies on the BTG website.
London, UK, 07 January 2014
BTG plc (LSE: BTG), the specialist healthcare company today announces that Louise Makin, CEO will be presenting an overview of the company at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, 15 January at 9am local (PST) time.
A PDF of the presentation will be available on BTG’s website at the same time.
For further information please contact:
Andy Burrows, Director of Investor Relations
+44 (0)20 7575 1741; Mobile: +44 (0)7990 530605
Rolf Soderstrom, Chief Financial Officer
+44 (0)20 7575 0000
+44 (0)20 7831 3113
BTG is an international specialist healthcare company that is developing and commercializing products targeting acute care, cancer and vascular diseases. The company has diversified revenues from sales of its own marketed products and from royalties on partnered products, and is seeking to acquire new programmes and products to develop and market to specialist physicians.
Select CONTINUE to proceed to the BTG website or LEAVE to learn more at BSC.com